THE PHARMACOKINETICS AND IMMUNOGENICITY OF USTEKINUMAB AND ADALIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE: RESULTS FROM THE SEAVUE STUDY

Silvio Danese  1     James Izanec  2     Tony Ma  2     Omoniyi J. Adedokun  3     Christopher Gasink  2     Stephen B Hanauer  4     Ellen Scherl     Kamal Patel    
1 Humanitas Clinical and Research Center, Humanitas University,Milan,Italy
2 Janssen Scientific Affairs, LLC,Horsham,United States
3 Janssen Research & Development, LLC,Spring House,United States
4 Northwestern University Feinb

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing